Antimicrobial Wound Care
Defeating biofilm Accelerating healing
Health Canada Approved
The Challenge
The wound care system is failing patients
Persistent biofilm and infection continue to delay healing, while conventional treatment often increases burden without consistently improving outcomes.
Chronic wounds affected by biofilm.[01]
An amputation occurs in the U.S.[02]
Mortality after the amputation.[03]
Average treatment burden per patient.[04]
The ComBatic™ Platform
A new class of antimicrobial. Built differently
ComBatic™ is built on a synergistic combination of plant-based small molecules and inorganic salts. Unlike conventional antimicrobials that attack a single pathway, ComBatic™ acts simultaneously across four bacterial processes — cell membrane disruption, Fe–S cluster interference, reactive oxygen species (ROS) pathway disruption, and sulfur homeostasis targeting — making resistance development significantly less likely.
Broad-spectrum
Effective against bacteria, fungi, and resistant strains
Antibiofilm
Disrupts and clears mature biofilm in 2–5 minutes
Anti-inflammatory
Elevates glutathione (GSH), a natural antioxidant
Low resistance risk
Multi-target mechanism limits AMR development
01
Cleanse & Disrupt
ComBatic™ Wound Lavage: Apply the lavage solution to irrigate the wound. No scraping. No bleeding. No trauma to surrounding tissue.
02
Protect & Heal
ComBatic™ Wound Hydrogel Healing Matrix: Apply the hydrogel directly to the debrided wound. Sustains antimicrobial activity while maintaining an optimal moist healing environment to accelerate tissue regeneration.
Our Products
A Complete Wound Care System
ComBatic™ Antimicrobial Wound Lavage Spray
- $16.99
- $16.99
- Unit price
- per
ComBatic™ Antimicrobial Wound Lavage
- $14.99
- $14.99
- Unit price
- per
ComBatic™ Antimicrobial Wound Hydro-Gel
- $19.99
- $19.99
- Unit price
- per
ComBatic™
Engineered for real outcomes
Clinically developed, non-antibiotic healing support to reduce infection risk and improve patient outcomes.
Effective against 17 WHO priority pathogens
Broad-spectrum action against Gram-positive, Gram-negative bacteria, fungi, and biofilm.[05]
Faster Healing
Supports natural recovery and helps wounds heal quicker.[06]
Antibiotic-Free
No risk of resistance. Safe for repeated use.[07]
Safe & Skin-Friendly
Gentle, non-toxic, and suitable for regular application.[08]
Clinical Evidence & Competitive Advantage
Proven performance. Measurable outcomes
▶
Latest News
Ready when you are
Transform wound care outcomes today
Clinically validated solutions designed to disrupt biofilms, reduce infection, and support faster recovery
References
(01). More than 78% of chronic wounds contain biofilm
Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. Journal of Wound Care. 2017;26(1):20-25. https://pubmed.ncbi.nlm.nih.gov/28103163/.
(02). Every 30 seconds a lower limb is amputated globally as a consequence of diabetes
Bilal M, et al. Socioeconomic Deprivation as a Predictor of Lower Limb Amputation in Diabetic Foot Disease. PMC10543925. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10543925/.
(03). Nearly 50% mortality within 5 years of a diabetic foot ulcer diagnosis
Jiang Y, et al. Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies. Diabetes/Metabolism Research and Reviews. 2022. PubMed ID: 36054820. https://pubmed.ncbi.nlm.nih.gov/36054820/.
(04). Up to $16,000 average treatment cost per diabetic foot ulcer episode
Stockl K, et al. Costs of Lower-Extremity Ulcers Among Patients With Diabetes. Diabetes Care. 2004;27(9):2129-2134. https://diabetesjournals.org/care/article/27/9/2129 /22597/.
(05). Effective against 17 WHO priority pathogens:
— MHCombiotic Published Data Addendum, Fig. 3 (heat map — efficacy against 17 WHO priority pathogens including bacteria and fungi)
— Pormohammad A, et al. Nanomaterials in wound healing and infection control. Antibiotics. 2021;10(5):473.
(06). Faster Healing:
— MHCombiotic Published Data Addendum, Fig. 6 & 7 (MRSA mouse wound model — bacterial load reduction and wound closure vs. Prontosan and saline)
(07). Antibiotic-Free — No risk of resistance:
— MHCombiotic Published Data Addendum, Future Resistance Studies section
— Pormohammad A, Greening D, Turner RJ. Synergism inhibition and eradication activity of silver nitrate/potassium tellurite combination against Pseudomonas aeruginosa biofilm. Journal of Antimicrobial Chemotherapy. 2022;77(6):1635-44.
(08). Safe & Skin-Friendly:
— MHCombiotic Published Data Addendum, Tables 2 & 3 (ISO 10993 full biocompatibility suite — cytotoxicity, acute systemic toxicity, sensitization, pyrogenicity, irritation; conducted by Geneva Laboratories under GLP/GMP)
- Choosing a selection results in a full page refresh.